These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5334474)

  • 21. [New approaches in the chemotherapy of depressive conditions using Anafranil].
    Dickhaut HH; Galiatsatos P
    Nervenarzt; 1968 Dec; 39(12):552-6. PubMed ID: 5733572
    [No Abstract]   [Full Text] [Related]  

  • 22. [Trial of verification of the thymoanaleptic action of hypothalamic thyrostimulin (thyrotropin releasing factor of TRF) in melancholic states].
    Zarifian E; Cottereau MJ; Loo H; Ginestet D; Deniker P
    Encephale; 1975; 1(1):9-14. PubMed ID: 805696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramuscular nialamide in depressed patients (a biochemical study).
    Pare CM; Jenner GC
    Dis Nerv Syst; 1966 Mar; 27(3):193-4. PubMed ID: 5908305
    [No Abstract]   [Full Text] [Related]  

  • 24. Scopolamine sleep treatment in private practise.
    Goldner RD
    Int J Neuropsychiatry; 1967 Jun; 3(3):234-47. PubMed ID: 6039771
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analgesic and antidepressive: nialamide in cancerology. Value of parenteral administration].
    Proux C; Toubiana CG
    Clinique (Paris); 1965 May; 60(607):388-91. PubMed ID: 5833447
    [No Abstract]   [Full Text] [Related]  

  • 26. [Action of dipotassium clorazepate in combination with insulin in the treatment of depressive states].
    Guyot MP
    Ann Med Psychol (Paris); 1974 May; 1(5):627-31. PubMed ID: 4433108
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preliminary results of the use of chlorimipramine administered by drip phleboclysis in therapy of depressive states].
    Campailla G
    G Psichiatr Neuropatol; 1966; 94(4):857-68. PubMed ID: 5995940
    [No Abstract]   [Full Text] [Related]  

  • 28. [PARENTERAL NIAMID IN LARGE DOSES IN DEPRESSIVE SYNDROMES. (ATTEMPTED CORRELATION OF THE CLINICAL AND BIOLOGICAL ASPECTS)].
    BAREK A; BURGERMEISTER JJ; REY-BELLET J; TISSOT R; DE AJURIAGUERRA J
    Psychiatr Neurol (Basel); 1964; 148():257-70. PubMed ID: 14249620
    [No Abstract]   [Full Text] [Related]  

  • 29. Lithium treatment of depression.
    Noyes R; Dempsey GM
    Dis Nerv Syst; 1974 Dec; 35(12):573-6. PubMed ID: 17896758
    [No Abstract]   [Full Text] [Related]  

  • 30. Tryptophan and an MAOI (nialamide) in the treatment of depression. A double-blind study.
    Ayuso Gutierrez JL; Aliño JJ
    Int Pharmacopsychiatry; 1971; 6(2):92-7. PubMed ID: 4950287
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical study of an anxiolytic antidepressive drug].
    Bolzani L; Slivar G
    Psychiatr Neurol (Basel); 1967; 153(5):301-7. PubMed ID: 5339994
    [No Abstract]   [Full Text] [Related]  

  • 32. [EXPERIENCE IN THE USE OF INJECTABLE BENZYLCARBAMOYLHYDRAZINE (NIAMIDE) IN DEPRESSION].
    HEPPDUBIAU J
    Rev Med Chil; 1964 Mar; 92():243-4. PubMed ID: 14169693
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of niamide in coronary disease].
    Markiewicz M
    Pol Tyg Lek; 1969 Jul; 24(29):1129-31. PubMed ID: 4897262
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical trial of neuropton (nialamide-hydroxyzine pamoate)].
    Bourgeois M
    Ann Med Psychol (Paris); 1970 Jan; 1(1):134-8. PubMed ID: 5421306
    [No Abstract]   [Full Text] [Related]  

  • 35. The action of antidepressants and convulsive treatment upon the higher nervous activity in depressive states.
    Saarma J; Saarma M
    Cond Reflex; 1973; 8(1):57-60. PubMed ID: 4714916
    [No Abstract]   [Full Text] [Related]  

  • 36. [1st therapeutic experience with intravenous nialamide in high doses in depressive syndromes].
    NISTRI M; GERMANO G; SGAMBATI M
    Rass Studi Psichiatr; 1962; 51():332-6. PubMed ID: 13938832
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of treatment of depressive states with melitracen].
    Madejska N; Mika M; Pańkow T
    Psychiatr Pol; 1967; 1(4):463-71. PubMed ID: 5595168
    [No Abstract]   [Full Text] [Related]  

  • 38. 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study.
    Aliño JJ; Gutierrez JL; Iglesias ML
    Int Pharmacopsychiatry; 1976; 11(1):8-15. PubMed ID: 770365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical experiences with the antidepressant Noveril in the treatment of depressions at a later age].
    Arnold OH; Guss H
    Wien Klin Wochenschr; 1966 Dec; 78(51):913-5. PubMed ID: 5973397
    [No Abstract]   [Full Text] [Related]  

  • 40. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
    Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
    Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.